Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 4,300 shares, a decrease of 97.2% from the November 30th total of 154,900 shares. Based on an average daily volume of 721,100 shares, the short-interest ratio is currently 0.0 days.
Analyst Upgrades and Downgrades
RBGLY has been the topic of several recent research reports. Barclays upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. Sanford C. Bernstein cut shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 4th. Citigroup upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Tuesday, October 1st. JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a report on Thursday, August 29th. Finally, UBS Group upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. Three research analysts have rated the stock with a hold rating, one has assigned a buy rating and four have issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy”.
Read Our Latest Report on RBGLY
Reckitt Benckiser Group Trading Up 0.1 %
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
- Five stocks we like better than Reckitt Benckiser Group
- How to Calculate Stock Profit
- Top 3 Investment Themes to Watch for in 2025
- 3 REITs to Buy and Hold for the Long Term
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- CD Calculator: Certificate of Deposit Calculator
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.